Evidence map›Paper›PMID 22705496›Full record

ArticleStem cell research2012

The abundance of Rad51 protein in mouse embryonic stem cells is regulated at multiple levels.

Elisia D Tichy, Resmi Pillai, Li Deng, Jay A Tischfield, Philip Hexley, George F Babcock, Peter J Stambrook

Abstract read
In one paragraph

Article in Stem cell research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Phosphorylation and DNA damage resolution coordinate SOX2-mediated reprogramming in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Wnts and the hallmarks of cancer.Cancer metastasis reviews · 2020
    Review
  7. Article
  8. Article
  9. Combined Ectopic Expression of Homologous Recombination Factors Promotes Embryonic Stem Cell Differentiation.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Elisia D TichyDepartment of Molecular Genetics, University of Cincinnati, College of Medicine, Cincinnati OH 45267, USA. tichyed@ucmail.uc.edu
Resmi Pillai
Li Deng
Jay A Tischfield
Philip Hexley
George F Babcock
Peter J Stambrook
Rutgers, The State University of New Jersey · USUniversity of Cincinnati Medical Center · USUniversity of Cincinnati · US

Funding

Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY RESEARCHP30ES006096 · NIEHS · UNIVERSITY OF CINCINNATI · PI YADAV, JAGJIT S · 1992 to 2022
$35.4M
ENVIRONMETAL CARCINOGENESIS AND MUTAGENESIST32ES007250 · NIEHS · UNIVERSITY OF CINCINNATI · PI MILLER, WILLIAM E · 1988 to 2024
$11.9M
Environmental exposure: Susceptibility alleles in a DNA damage response pathwayR01ES016625 · NIEHS · UNIVERSITY OF CINCINNATI · PI STAMBROOK, PETER J. · 2009 to 2013
$2.5M
Mouse Model for Chemical and Radiation MutagenesisR01ES011633 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI TISCHFIELD, JAY ARNOLD · 2002 to 2006
$1.9M
Pathways to Mutagenesis in vivo and in Stem CellsR01ES012695 · NIEHS · UNIVERSITY OF CINCINNATI · PI STAMBROOK, PETER J. · 2006 to 2009
$1.7M
NIEHS NIH HHS ES011633NIEHS NIH HHS P30 ES005022NIEHS NIH HHS P30 ES006096NIEHS NIH HHS R01 ES011633NIEHS NIH HHS R01 ES012695NIEHS NIH HHS R01 ES016625NIEHS NIH HHS R01 ES12695-4S1NIEHS NIH HHS T32 ES007250
6 · The paper itself

Abstract

DNA double-strand breaks (DSBs) in embryonic stem (ES) cells are repaired primarily by homologous recombination (HR). The mechanism by which HR is regulated in these cells, however, remains enigmatic. To gain insight into such regulatory mechanisms, we have asked how protein levels of Rad51, a key component of HR, are controlled in mouse ES cells and mouse embryo fibroblasts (MEFs). The Rad51 protein level is about 15-fold higher in ES cells than in MEFs. The level of Rad51 mRNA, however, is only ~2-fold higher, indicating that the differences in mRNA levels due to rates of transcription or mRNA stability are not sufficient to account for the large difference in the abundance of Rad51 protein. Comparison of Rad51 half-lives between ES cells and MEFs also did not explain the elevated level of Rad51 protein in the ES cells. A comparative assessment of the Rad51 translation level demonstrated that it is translated with much greater efficacy in ES cells than in MEFs. To determine whether this high level of translation in ES cells is a general phenomenon in these cells or whether it is a characteristic of specific proteins, such as those involved with recombination and cell cycle progression, we compared mechanisms that regulate the level of Pcna in ES cells with those that regulate Rad51. The half-life of Pcna and its rate of synthesis were considerably different from those of Rad51 in ES cells, demonstrating that regulation of Rad51 abundance cannot be generalized to other ES cell proteins and not to proteins involved in DNA replication and cell cycle control. Finally, we show that only a small proportion of the abundant Rad51 protein population is activated under basal conditions in ES cells and recruited to DNA DSBs and/or stalled replication forks.

Indexed as

AnimalsDNA Breaks, Double-StrandedDNA RepairDNA ReplicationE2F Transcription FactorsEmbryo, MammalianEmbryonic Stem CellsFibroblastsGene Expression RegulationMiceProliferating Cell Nuclear AntigenProtein BiosynthesisProtein StabilityRad51 RecombinaseE2F Transcription FactorsProliferating Cell Nuclear AntigenRad51 protein, mouseRad51 Recombinase

Identifiers

PMID22705496
PMCPMC3412895
OpenAlexW2050706523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.